BioCorRx Inc.
BICX
$0.35
-$0.0594-14.51%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 755.46% | 166.09% | -91.46% | -82.68% | -84.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 755.46% | 166.09% | -91.46% | -82.68% | -84.58% |
| Cost of Revenue | -100.00% | -100.00% | -95.29% | -53.31% | -37.87% |
| Gross Profit | 1,620.33% | 491.06% | -88.74% | -90.21% | -91.22% |
| SG&A Expenses | 40.46% | 32.49% | 25.65% | 19.61% | -1.58% |
| Depreciation & Amortization | 334.70% | 91.04% | 23.51% | -0.74% | -1.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.01% | 39.39% | 33.98% | 13.89% | -5.63% |
| Operating Income | -24.58% | -37.61% | -36.97% | -17.49% | 1.14% |
| Income Before Tax | -15.37% | -20.74% | -38.24% | -24.95% | -6.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.37% | -20.74% | -38.24% | -24.95% | -6.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,178.42% | 3,302.94% | 2,844.44% | 590.48% | 167.61% |
| Net Income | -10.21% | -17.94% | -35.55% | -24.05% | -6.13% |
| EBIT | -24.58% | -37.61% | -36.97% | -17.49% | 1.14% |
| EBITDA | -22.56% | -37.21% | -37.06% | -17.60% | 1.14% |
| EPS Basic | 26.36% | 11.12% | -9.86% | -5.39% | 7.53% |
| Normalized Basic EPS | 33.52% | 16.34% | -7.63% | -14.57% | -4.16% |
| EPS Diluted | 26.36% | 11.31% | -9.62% | -5.17% | 7.71% |
| Normalized Diluted EPS | 33.52% | 16.34% | -7.63% | -14.57% | -4.16% |
| Average Basic Shares Outstanding | 57.53% | 40.13% | 25.40% | 16.46% | 13.98% |
| Average Diluted Shares Outstanding | 57.53% | 40.13% | 25.40% | 16.46% | 13.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |